A cancer diagnosis is often an uphill battle for patients, but the physicians and staff at North Mississippi Hematology & Oncology Associates have been arming themselves against the deadly disease for nearly 30 years.
Since 1979, Tupelo’s HOA has provided patients in North Mississippi, Northwest Alabama and Southwest Tennessee the highest quality treatments for blood disorders, as well as clinical trials not frequently offered in this region.
At Hematology and Oncology Associates at BridgePoint, the 51,000-square-foot facility on South Gloster Street welcomes 300 oncology patients a day.
“Because our new facility was designed around patients’ needs, we wanted to give it a name that related to a patient’s journey through treatment,” says the groups’ co-founder, Dr. Charles Montgomery. “As physicians, we also wanted to acknowledge how patients often rely on us for guidance and support as they navigate the challenges of fighting cancer.”
Situated on 9 acres, the modern clinic includes five waiting areas, 17 private patient rooms and 42 chemotherapy bays. Patients also enjoy the convenience of an in-house pharmacy, while a glass-front lobby, 10-foot-deep saltwater aquarium and open-air courtyard provide a tranquil escape between treatments.
Staffed by six physicians, two nurse practitioners and more than 50 employees, the facility offers patients specialized treatments, including chemotherapy and immunotherapy treatments, biological response modifiers and various supportive therapies. HOA also operates satellite facilities in nearby Columbus and Corinth, Miss.
“As our practice has developed, we have grown with the changes,” Montgomery says. “We opened our satellite facilities as a way to take care of our patients close to home. We added research early on because cancer treatment is constantly changing, and our research department continues to grow with it. As new innovative therapies are being developed every day, we want to continue to be a frontline participant.”
HOA’s expanded research facility allows for greater involvement in clinical trials, which keeps the group’s physicians in the know on up-and-coming treatment options.
In the past few years, Hematology and Oncology Associates has worked with numerous pharmaceutical groups on cutting-edge research, including Genentech, Pfizer, Roche, GlaxoSmithKline, Ortho Biotech and Johnson & Johnson.
“We’re trying to put cancer out of business and ultimately push ourselves out of a job,” says Dr. Christopher Croot, who, along with Drs. Julian Hill, Andrew Kellum, David Morris, Charles Montgomery and Brian Walker comprise HOA’s physician team. “We want to continually expand and add services that will help our patients and their families deal with the overall cancer experience.”
Find out more about Tupelo, MS health and health care.